HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

HENGRUI PHARMA

46.040

-0.020-0.04%

Volume:801.80K

Turnover:37.06M

Market Cap:305.57B

PE:33.45

High:46.500

Open:46.380

Low:45.920

Close:46.060

52wk High:94.869

52wk Low:45.660

Shares:6.64B

HK Float Shares:258.00M

Volume Ratio:0.34

T/O Rate:0.31%

Dividend:0.23

Dividend Rate:0.51%

EPS(LYR):1.376

ROE:12.46%

ROA:7.02%

PB:4.06

PE(LYR):33.45

PS:8.36

Loading ...

Overview Company News Filings

Hong Kong Stocks in Focus: METIS TECHBIO-P (07666) Surges Over 16% in Morning Trade as In-House AiTEM Platform Integrates with Jiangsu Hengrui Pharmaceuticals

Hengrui Pharma Prioritizes Stable Business Performance to Sustain Long-Term Value and Reward Shareholders

HENGRUI PHARMA Continues to Reward Shareholders Through Dividends and Other Methods

Jiangsu Hengrui Pharmaceuticals Focuses on Core Business Growth

Citigroup's Short Position in H-Shares of Jiangsu Hengrui Pharmaceuticals Decreases to 1.39% on Aug 3 from 2.36% - HKEX

THOMSON REUTERS

August 7th A-H Share Premium Data Summary

HENGRUI PHARMA Shares Surge Over 4% in Late Trading as China's First Anti-HER2 Product for Colorectal Cancer Gains Market Approval

Movement Alert｜HENGRUI PHARMA Rises 3.1% in Regular Trading, Two Innovative Drugs Approved for New Indications

Hengrui Pharma Unit Gets Marketing Nod for Colorectal Cancer Drug in China

MT Newswires Live

Hengrui Pharma Secures China’s First Anti-HER2 Approval for Colorectal Cancer with Trastuzumab Rezetecan

Bulletin Express

Jiangsu Hengrui Pharmaceuticals - Nmpa Approved Additional (Fifth) Indication for Ivarmacitinib Sulfate Tablets (Shr0302 Tablets)

THOMSON REUTERS

Jiangsu Hengrui Pharmaceuticals - Nmpa Approves Third Indication for Trastuzumab Rezetecan for Injection for Marketing in China

THOMSON REUTERS

JAK1 Inhibitor Aisuda Secures Fifth Indication Approval for Active Non-Radiographic Axial Spondyloarthritis

Jiangsu Hengrui Pharmaceuticals Secures Approval for Third Indication of Its Anti-HER2 Injection

Citigroup’s Long Position in H-Shares of Jiangsu Hengrui Pharmaceuticals Increases to 5.06% on July 31 from 4.46% - HKEX Filing

THOMSON REUTERS

HENGRUI PHARMA's Zhang Lianshan: Global Strategy at a Turning Point, Innovative Drug Firms Must Ultimately Go Global Independently

Movement Alert｜HENGRUI PHARMA Falls 3.09% in Regular Trading, Trading at HK$56.35

Cross-Market Valuation Disparities: Top A-H Share Premium Rankings as of August 5th

Hengrui Pharmaceuticals Gets China Nod for Lung Cancer Combo Trials

MT Newswires Live

Hengrui Pharma Completes 13.75 Million Share Buyback as of July 31

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/01276/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01276","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01276\",,,,,undefined,":{"symbol":"01276","market":"HK","secType":"STK","nameCN":"HENGRUI PHARMA","latestPrice":46.04,"timestamp":1788232117677,"preClose":46.06,"halted":0,"volume":801800,"delay":0,"changeRate":-0.00043421623968743214,"floatShares":258000000,"shares":6637000000,"eps":1.376305929200765,"marketStatus":"Trading","change":-0.02,"latestTime":"09-01 11:08:41","open":46.38,"high":46.5,"low":45.92,"amount":37055516,"amplitude":0.012592,"askPrice":46.1,"askSize":9400,"bidPrice":46.02,"bidSize":1600,"shortable":3,"etf":0,"ttmEps":1.3572825819929137,"tradingStatus":2,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1788235200000},"marketStatusCode":2,"adr":0,"listingDate":1747929600000,"exchange":"SEHK","adjPreClose":46.06,"dividendRate":0.005068,"openAndCloseTimeList":[[1788226200000,1788235200000],[1788238800000,1788249600000]],"volumeRatio":0.337516,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"600276","market":"SH","secType":"STK","nameCN":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd.","latestPrice":46.1,"timestamp":1788232119000,"preClose":46.07,"halted":0,"volume":26667800,"delay":0,"premium":"-14.37"}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01276\",,,,,undefined,":{"symbol":"01276","floatShares":258000000,"roa":"7.02%","roe":"12.46%","lyrEps":1.376306,"volumeRatio":0.337516,"shares":6637000000,"dividePrice":0.233272,"high":46.5,"amplitude":0.012592,"preClose":46.06,"low":45.92,"week52Low":45.66,"pbRate":"4.06","psRate":"8.36","week52High":94.869,"institutionHeld":0,"latestPrice":46.04,"committee":-0.709091,"eps":1.376305929200765,"divideRate":0.005067,"volume":801800,"delay":0,"ttmEps":1.3572825819929137,"open":46.38,"prevYearClose":71.002,"prevWeekClose":47.94,"prevMonthClose":46.06,"prevQuarterClose":57.85,"fiveDayClose":46.5,"twentyDayClose":57.65,"sixtyDayClose":54.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01276\",params:#limit:5,,,undefined,":[{"date":"2026-08-19","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787103000000,"name":null,"time":"","dateTimestamp":1787068800000,"actualEps":null},{"date":"2026-04-29","symbol":"01276","amount":0.22828,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2026-04-30","defaultRemindTime":1777426200000,"name":"恒瑞医药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-27","payableDate":"2026-04-30","currency":"HKD","dateTimestamp":1777392000000,"payDate":"2026-05-27"},{"date":"2026-04-22","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1776821400000,"name":null,"time":"","dateTimestamp":1776787200000,"actualEps":null},{"date":"2026-03-26","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774488600000,"name":null,"time":"","dateTimestamp":1774454400000,"actualEps":null},{"date":"2025-10-28","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1761615000000,"name":null,"time":"","dateTimestamp":1761580800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01276\",market:\"HK\",,,undefined,":[{"executeDate":"2026-04-29","recordDate":"2026-04-30","paymentDate":"2026-05-27","value":0.22828,"currency":"HKD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01276\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.2727,"buy":0.5455,"hold":0.1818,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5455,"analysts":11,"updateTime":1786896000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01276\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01276","date":"2026-08-31","current":33.920718,"percent":0.035032,"low":37.44534,"twenty":44.126967,"median":51.795913,"eighty":57.30426,"high":65.582363,"avg":51.569018,"sd":7.166165,"marketCap":353553063386.94},"quantilePoints":[{"date":"2025-05-23","current":52.570963,"twenty":52.783176,"median":53.101495,"eighty":53.419815,"marketCap":390693388207.53},{"date":"2025-05-30","current":53.015805,"twenty":51.822085,"median":52.540895,"eighty":52.926837,"marketCap":395731540422.24},{"date":"2025-06-06","current":52.120101,"twenty":52.130014,"median":52.555929,"eighty":53.075252,"marketCap":390038198012.59},{"date":"2025-06-13","current":52.209491,"twenty":52.177631,"median":52.691227,"eighty":53.357137,"marketCap":390861633032.23},{"date":"2025-06-20","current":50.172412,"twenty":51.591196,"median":52.469796,"eighty":53.075252,"marketCap":374874997562.85},{"date":"2025-06-27","current":50.314776,"twenty":50.363569,"median":52.169666,"eighty":53.013533,"marketCap":376991477472.78},{"date":"2025-07-04","current":51.666141,"twenty":50.343584,"median":52.120101,"eighty":53.004446,"marketCap":387134991658.26},{"date":"2025-07-11","current":55.507007,"twenty":50.44351,"median":52.13337,"eighty":53.090114,"marketCap":415495681161.23},{"date":"2025-07-18","current":57.272274,"twenty":50.582121,"median":52.209491,"eighty":54.057606,"marketCap":428373566715.29},{"date":"2025-07-25","current":54.897923,"twenty":50.594414,"median":52.555929,"eighty":55.711415,"marketCap":412107620053.2},{"date":"2025-08-01","current":59.731878,"twenty":50.855059,"median":52.994419,"eighty":55.972407,"marketCap":445624526286.47},{"date":"2025-08-08","current":59.478715,"twenty":51.107295,"median":53.05296,"eighty":56.541585,"marketCap":444845815775.64},{"date":"2025-08-15","current":61.917611,"twenty":51.356483,"median":53.519848,"eighty":59.478715,"marketCap":462392609292.46},{"date":"2025-08-22","current":58.782188,"twenty":51.569512,"median":54.477764,"eighty":60.15932,"marketCap":470428104569.66},{"date":"2025-08-29","current":59.85298,"twenty":51.666141,"median":55.691374,"eighty":59.937003,"marketCap":481284287403.35},{"date":"2025-09-05","current":65.582363,"twenty":51.677932,"median":55.770266,"eighty":60.732448,"marketCap":526832269752.24},{"date":"2025-09-12","current":62.481332,"twenty":51.8337,"median":55.972407,"eighty":61.285609,"marketCap":502824785657.99},{"date":"2025-09-19","current":63.179889,"twenty":52.120101,"median":56.254853,"eighty":61.852995,"marketCap":508085671393.42},{"date":"2025-09-26","current":63.528382,"twenty":52.146639,"median":56.965096,"eighty":62.270337,"marketCap":509562668601.01},{"date":"2025-10-03","current":64.989073,"twenty":52.165061,"median":57.272274,"eighty":62.504861,"marketCap":522523002865.02},{"date":"2025-10-10","current":61.782766,"twenty":52.193561,"median":59.039802,"eighty":62.657943,"marketCap":496019912951.91},{"date":"2025-10-17","current":58.903713,"twenty":52.323014,"median":59.170669,"eighty":62.619084,"marketCap":472537436949.31},{"date":"2025-10-24","current":59.187086,"twenty":52.484015,"median":59.039802,"eighty":62.52839,"marketCap":474983377696.11},{"date":"2025-10-31","current":57.072441,"twenty":52.552922,"median":59.021138,"eighty":62.417499,"marketCap":465758305542.93},{"date":"2025-11-07","current":54.713071,"twenty":52.619069,"median":58.881843,"eighty":62.304573,"marketCap":446224987036.64},{"date":"2025-11-14","current":55.883072,"twenty":52.812504,"median":58.231971,"eighty":62.27542,"marketCap":457058673340.29},{"date":"2025-11-21","current":52.805265,"twenty":52.880927,"median":57.030538,"eighty":62.209511,"marketCap":431684582485.14},{"date":"2025-11-28","current":55.237621,"twenty":52.99843,"median":56.630614,"eighty":62.069705,"marketCap":453209419829.34},{"date":"2025-12-05","current":54.841023,"twenty":53.00899,"median":56.437545,"eighty":61.965159,"marketCap":450729029423.46},{"date":"2025-12-12","current":56.212257,"twenty":53.045529,"median":56.385682,"eighty":61.891765,"marketCap":462853512587.19},{"date":"2025-12-19","current":54.083493,"twenty":53.045529,"median":56.227363,"eighty":61.831221,"marketCap":446374731108.34},{"date":"2025-12-24","current":54.414957,"twenty":53.090114,"median":56.103073,"eighty":61.798561,"marketCap":450509359276.9},{"date":"2026-01-02","current":53.078544,"twenty":53.065996,"median":55.972407,"eighty":61.785925,"marketCap":441174507319.22},{"date":"2026-01-09","current":56.743223,"twenty":53.0878,"median":56.0944,"eighty":61.695241,"marketCap":472808676524.34},{"date":"2026-01-16","current":55.187351,"twenty":53.304215,"median":56.103073,"eighty":61.405393,"marketCap":461338821289.95},{"date":"2026-01-23","current":52.546341,"twenty":53.0878,"median":56.076447,"eighty":61.296167,"marketCap":438839874056.97},{"date":"2026-01-30","current":51.677141,"twenty":52.994149,"median":55.908509,"eighty":61.278475,"marketCap":433553740508.2},{"date":"2026-02-06","current":50.918226,"twenty":52.680723,"median":55.839154,"eighty":61.101743,"marketCap":428270226283.58},{"date":"2026-02-13","current":51.771686,"twenty":52.512455,"median":55.711415,"eighty":60.890064,"marketCap":437949787160.49},{"date":"2026-02-20","current":51.752043,"twenty":52.351169,"median":55.691374,"eighty":60.824953,"marketCap":437153052005.04},{"date":"2026-02-27","current":50.215456,"twenty":52.151244,"median":55.507566,"eighty":60.720339,"marketCap":428825318404.97},{"date":"2026-03-06","current":49.335298,"twenty":51.80347,"median":55.280584,"eighty":60.654676,"marketCap":417912584744.19},{"date":"2026-03-13","current":48.90444,"twenty":51.75217,"median":55.201025,"eighty":60.572606,"marketCap":416170839186.33},{"date":"2026-03-20","current":48.948437,"twenty":51.671435,"median":55.086674,"eighty":60.515374,"marketCap":414967977646.95},{"date":"2026-03-27","current":47.483832,"twenty":51.400677,"median":54.94883,"eighty":60.443129,"marketCap":414588875872.42},{"date":"2026-04-02","current":49.302243,"twenty":51.107295,"median":54.905743,"eighty":60.227005,"marketCap":432534434303.11},{"date":"2026-04-10","current":49.055344,"twenty":50.995993,"median":54.897923,"eighty":60.186394,"marketCap":433687668394.36},{"date":"2026-04-17","current":48.417764,"twenty":50.589497,"median":54.65026,"eighty":60.143018,"marketCap":428230701835.75},{"date":"2026-04-24","current":45.835792,"twenty":50.342877,"median":54.475147,"eighty":60.015062,"marketCap":426879682872.04},{"date":"2026-04-30","current":44.026312,"twenty":50.285416,"median":54.355253,"eighty":59.903394,"marketCap":410132737659.64},{"date":"2026-05-08","current":43.161515,"twenty":50.207478,"median":54.262074,"eighty":59.804539,"marketCap":403472171949.3},{"date":"2026-05-15","current":44.128138,"twenty":49.985706,"median":54.115335,"eighty":59.70386,"marketCap":413593092820.6},{"date":"2026-05-22","current":41.244553,"twenty":49.583265,"median":53.983854,"eighty":59.631568,"marketCap":385683097978.4},{"date":"2026-05-29","current":40.98659,"twenty":49.34142,"median":53.840414,"eighty":59.564678,"marketCap":384603594259.51},{"date":"2026-06-05","current":38.394132,"twenty":49.063316,"median":53.633194,"eighty":59.459458,"marketCap":360799766229.36},{"date":"2026-06-12","current":39.515262,"twenty":48.81081,"median":53.517715,"eighty":59.36625,"marketCap":371084155232.86},{"date":"2026-06-18","current":39.444808,"twenty":48.417764,"median":53.467699,"eighty":59.301536,"marketCap":371311256576.18},{"date":"2026-06-26","current":39.60241,"twenty":47.951326,"median":53.090114,"eighty":59.187086,"marketCap":370974287810.31},{"date":"2026-07-03","current":44.319925,"twenty":47.638943,"median":53.015805,"eighty":59.069259,"marketCap":415476044901.86},{"date":"2026-07-10","current":45.319748,"twenty":47.348429,"median":52.993744,"eighty":59.024871,"marketCap":424327469311.14},{"date":"2026-07-17","current":43.189222,"twenty":46.151454,"median":52.805265,"eighty":58.96135,"marketCap":405818502739.33},{"date":"2026-07-24","current":43.433009,"twenty":45.632553,"median":52.604835,"eighty":58.912251,"marketCap":408200902707.63},{"date":"2026-07-31","current":43.935338,"twenty":45.29749,"median":52.543618,"eighty":58.877468,"marketCap":413706414238.87},{"date":"2026-08-07","current":44.394532,"twenty":45.008473,"median":52.339287,"eighty":58.813302,"marketCap":418841988303.56},{"date":"2026-08-14","current":42.6704,"twenty":44.628794,"median":52.189578,"eighty":58.452058,"marketCap":403085247281.44},{"date":"2026-08-21","current":40.686911,"twenty":44.408765,"median":52.120101,"eighty":57.75211,"marketCap":366558497066.13},{"date":"2026-08-28","current":40.334802,"twenty":44.24321,"median":51.814807,"eighty":57.336246,"marketCap":363468645736.13},{"date":"2026-08-31","current":39.251146,"twenty":44.126967,"median":51.795913,"eighty":57.30426,"marketCap":353553063386.94}],"updateTime":1788232121649},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01276\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1127214106","title":"Hong Kong Stocks in Focus: METIS TECHBIO-P (07666) Surges Over 16% in Morning Trade as In-House AiTEM Platform Integrates with Jiangsu Hengrui Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=1127214106","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127214106?lang=en_us&edition=fundamental","pubTime":"2026-08-10 09:38","pubTimestamp":1786325900,"startTime":"0","endTime":"0","summary":"METIS TECHBIO-P (07666) shares climbed more than 16% during early trading on the Hong Kong Stock Exchange, last changing hands at HK$12.87, representing a 15.74% gain with turnover reaching...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0060","BK1191","CWC","LU1997245177.USD","TQQQ","09086","QQQ","MFIG","GK","LU2328871848.SGD","02834","LU2543165471.USD","07266","QQQM","LU1580142542.USD","BK4585","WPAI","LU1064131003.USD","600276","03086","LU1820825898.SGD","LU1328615791.USD","AQGX","QID","LU1997244956.HKD","07666","LU1997245094.SGD","BK0183","CPNQ","NJUL","VUSE","AIFD","QSWN","LU1146622755.USD","ARTY","01276","FWD","QMAR","BK0188","LU2148510915.USD","TARK","LU2580892789.USD","LU0359202008.SGD","QQQX","LU0359201612.USD","LU1655091616.SGD","07522","BK4593","BK0012","QQA","AIBU","KCAI","VXUS","DQJN","TECY","GPIQ","LU2097828557.USD","LU0405327148.USD","AIQU","LU1969619763.USD","LCLG","PBOT","LU1255011170.USD","03034","LU1781817850.SGD","AGIX","LU2580892862.HKD","PSQ","LU2097828474.EUR","LU2097828805.USD","LU1064130708.USD","LU0405327494.USD","BK4588","161631","07568","LU2488822045.USD","09834","LU1023057109.AUD","NOCT","LU2097828714.EUR","CHAT","07261","BK0239","LU2097828631.EUR","NAPR","OGIG","SQQQ","KOMP","BK0028","LU0359201885.HKD","NEWZ","NBDS","NJAN","LU2289578879.USD","TQQY","QTOC","BK0196","03455","QLD","MVPS","LU2495084118.USD","BK1161","QDEC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198378336","title":"Hengrui Pharma Prioritizes Stable Business Performance to Sustain Long-Term Value and Reward Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=1198378336","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198378336?lang=en_us&edition=fundamental","pubTime":"2026-08-07 22:41","pubTimestamp":1786113674,"startTime":"0","endTime":"0","summary":"On August 7, Jiangsu Hengrui Pharmaceuticals Co.,Ltd. (ticker: 600276) responded to investor inquiries on its interactive platform, stating that the company consistently adheres to a strategy of...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0012","BK0060","LU2495084118.USD","BK1191","LU1820825898.SGD","LU1997245177.USD","LU1064131003.USD","LU2097828714.EUR","BK0239","LU2580892789.USD","LU2097828631.EUR","LU2097828805.USD","LU2148510915.USD","LU1023057109.AUD","LU1146622755.USD","600276","BK0188","LU1969619763.USD","LU1655091616.SGD","LU1064130708.USD","BK0183","LU1997245094.SGD","LU1781817850.SGD","LU1255011170.USD","LU2328871848.SGD","LU0405327148.USD","LU1328615791.USD","LU0359201885.HKD","LU1580142542.USD","LU2097828474.EUR","LU2580892862.HKD","LU2543165471.USD","LU0359201612.USD","01276","LU1997244956.HKD","LU2097828557.USD","LU0359202008.SGD","LU0405327494.USD","BK0028","BK0196","LU2488822045.USD","LU2289578879.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107727624","title":"HENGRUI PHARMA Continues to Reward Shareholders Through Dividends and Other Methods","url":"https://stock-news.laohu8.com/highlight/detail?id=1107727624","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107727624?lang=en_us&edition=fundamental","pubTime":"2026-08-07 22:40","pubTimestamp":1786113627,"startTime":"0","endTime":"0","summary":"On August 7, Jiangsu Hengrui Pharmaceuticals Co.,Ltd. (HENGRUI PHARMA) responded to investor inquiries on its interactive platform, stating that since its A-share listing in 2000, the company raised...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276","LU2580892789.USD","LU1997245094.SGD","BK0188","LU1820825898.SGD","BK0060","BK4585","BK0183","LU1781817850.SGD","LU2328871848.SGD","LU1328615791.USD","LU2097828631.EUR","LU1580142542.USD","LU1997244956.HKD","BK0196","LU0405327494.USD","BK1191","LU2580892862.HKD","LU0359201612.USD","LU1146622755.USD","LU1064130708.USD","LU2097828714.EUR","VIG","LU2148510915.USD","BK0239","600276","BK0028","LU2097828805.USD","LU2488822045.USD","LU1064131003.USD","LU2495084118.USD","LU1023057109.AUD","LU1655091616.SGD","BK0012","BK4588","LU1969619763.USD","LU0359202008.SGD","LU0405327148.USD","LU2543165471.USD","LU2097828557.USD","LU2097828474.EUR","LU1997245177.USD","LU2289578879.USD","LU1255011170.USD","LU0359201885.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170067772","title":"Jiangsu Hengrui Pharmaceuticals Focuses on Core Business Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=1170067772","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170067772?lang=en_us&edition=fundamental","pubTime":"2026-08-07 20:21","pubTimestamp":1786105298,"startTime":"0","endTime":"0","summary":"On August 7, Jiangsu Hengrui Pharmaceuticals Co.,Ltd. responded to investor inquiries on its interactive platform, stating that secondary market stock price fluctuations are influenced by a...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276","LU1064130708.USD","LU1655091616.SGD","BK0028","LU0359202008.SGD","LU2495084118.USD","LU2097828805.USD","LU0405327148.USD","600276","LU1820825898.SGD","LU2097828631.EUR","LU2289578879.USD","BK0183","LU1023057109.AUD","BK0060","LU1580142542.USD","LU2097828714.EUR","LU1064131003.USD","BK0188","LU1255011170.USD","LU1997245094.SGD","LU1781817850.SGD","LU2148510915.USD","LU2097828557.USD","LU0405327494.USD","LU1328615791.USD","LU0359201885.HKD","LU2543165471.USD","LU2488822045.USD","LU2580892862.HKD","BK0239","LU2580892789.USD","BK0012","BK0196","LU1997245177.USD","LU1969619763.USD","LU2328871848.SGD","BK1191","LU0359201612.USD","LU1997244956.HKD","LU1146622755.USD","LU2097828474.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657199906","title":"Citigroup's Short Position in H-Shares of Jiangsu Hengrui Pharmaceuticals Decreases to 1.39% on Aug 3 from 2.36% - HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2657199906","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657199906?lang=en_us&edition=fundamental","pubTime":"2026-08-07 17:16","pubTimestamp":1786094172,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nFWN4432LB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0359201612.USD","LU1820825898.SGD","LU1064131003.USD","BK0188","01276","LU1023057109.AUD","LU0359201885.HKD","LU1969619763.USD","LU2148510915.USD","LU1655091616.SGD","LU1146622755.USD","LU2495084118.USD","LU2097828805.USD","LU2097828714.EUR","LU2097828557.USD","LU0405327494.USD","BK0239","LU0405327148.USD","BK1191","LU1255011170.USD","LU1997244956.HKD","LU2488822045.USD","BK0028","LU2580892862.HKD","LU1328615791.USD","LU2289578879.USD","LU2580892789.USD","LU2097828631.EUR","LU0359202008.SGD","LU1781817850.SGD","LU2097828474.EUR","LU1064130708.USD","600276","LU2543165471.USD","LU1997245094.SGD","LU1997245177.USD","BK0012","LU2328871848.SGD","BK0060","BK0183","BK0196","LU1580142542.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148550904","title":"August 7th A-H Share Premium Data Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=1148550904","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148550904?lang=en_us&edition=fundamental","pubTime":"2026-08-07 16:24","pubTimestamp":1786091046,"startTime":"0","endTime":"0","summary":"At the close of trading on August 7th, NE ELECTRIC (00042), ZHEJIANG SHIBAO (01057), and SINOPEC SSC (01033) held the top three positions in the A-H share premium ranking, with premiums of 1006.56%,...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1981816686.USD","BK1183","LU0384037296.USD","LU2125910500.SGD","LU0594300419.USD","LU0315178854.USD","01033","02208","LU0737861699.HKD","LU2424517915.HKD","LU0431992006.USD","LU0828237940.HKD","LU0164865239.USD","LU1242518857.USD","LU0979878070.USD","LU0054450605.USD","LU0488056044.USD","BK1163","LU0821914370.USD","LU0320764599.SGD","LU0708995583.HKD","LU0164880469.USD","00042","LU0348805143.USD","LU0819121731.USD","HK0000306685.HKD","LU0326950275.SGD","BK1135","LU0588545490.SGD","LU1044876610.USD","LU2045819591.USD","HK0000500386.USD","LU0359202008.SGD","LU0370786039.SGD","BK1202","00598","02465","LU0164872284.USD","LU0572944931.SGD","LU1044875133.USD","LU0762542818.HKD","LU0593848301.USD","00300","LU0348816934.USD","LU1282648689.USD","LU2226246903.HKD","LU1146622755.USD","LU0456846285.SGD","01688","BK1205","LU0211977185.USD","LU1008478684.HKD","02359","HPAD.SI","LU0235996351.USD","02768","BK1249","LU0359201612.USD","LU0214875030.USD","BK1151","LU1023057109.AUD","LU1820825898.SGD","SG9999002828.SGD","LU0831093199.SGD","SG9999001903.USD","06881","LU0516423174.USD","00568","LU0359201885.HKD","IE00BMCWC346.EUR","LU1282651048.USD","BK1535","LU0605514214.HKD","LU0880133367.SGD","LU1152091754.HKD","IE00B5MMRT66.SGD","LU0531970944.HKD","LU0823040885.USD","LU0449509016.USD","LU0117841782.USD","LU1515016050.SGD","IE00BVYPNQ40.USD","IE00BZ08YS42.EUR","BK1564","02338","LU0348735423.USD","00763","LU0315179316.USD","IE00BVYPNP33.GBP","01108","LU1675838814.USD","LU0254981946.USD","03145","LU1961090484.USD","LU0862451753.SGD","LU0052750758.USD","LU1366334578.USD","LU0630378692.HKD","LU0128522157.USD","03200","BK1513","LU0210526637.USD","LU1115378108.SGD","HK0000320223.HKD","LU0140636845.USD","BK1529","LU0797268264.HKD","LU0702159343.USD","LU0878005551.USD","LU1235295612.USD","LU0117844026.USD","BK1506","LU1808992512.USD","03308","LU0594300179.USD","EWH","IE0008368742.USD","BK1607","HK0001040168.HKD","LU1282649141.HKD","BK1514","BK1551","LU0181495838.USD","LU0650527681.SGD","LU1880383366.USD","LU0417516571.SGD","LU1769817179.HKD","IE00BZ08YR35.GBP","LU1831875114.USD","LU0871576103.HKD","LU1152091168.USD","LU0672654166.SGD","01057","LU0072462343.USD","LU0449515922.USD","LU0634319403.HKD","HK0000352382.USD","LU1813983027.USD","LU2476274308.USD","LU2348774022.SGD","LU1051769294.HKD","BK1166","BK1507","LU2293587155.HKD","LU1328277881.USD","LU0516423091.SGD","LU1880383440.USD","LU0417516738.SGD","LU0702159699.USD","LU2399975544.HKD","BK1144","BK1237","HK0000320264.USD","03986","IE00B0169L03.USD","LU0165289439.USD","LU1719994722.HKD","01276","BK1231","03968","LU0588545730.USD","SG9999014674.SGD","LU0287142896.SGD","LU0791591158.USD","LU1770034418.SGD","03750","PNGAY","BK1214","LU1769817096.USD","LU0072913022.USD","LU0502904849.HKD","IE0003895053.USD","BK1502","LU0348767384.USD","LU0640798160.USD","399300","LU0348766576.USD","BK1171","LU0149721374.USD","LU0918141887.USD","LU1166156734.SGD","LU2242644610.SGD","LU0543330566.HKD","LU0106252389.USD","SG9999011746.SGD","LU0348814723.USD","LU1303224171.USD","LU0651947912.USD","BK1558","BK1521","00956","LU2153592121.USD","LU0029875118.USD","LU0648948544.HKD","BK1550","IE00B29SXG58.USD","LU2778985437.USD","LU1251922891.USD","LU1282649810.SGD","LU2543165471.USD","LU0516422952.EUR","LU0898667661.SGD","LU0049853897.USD","LU0455707207.USD","LU1655091459.SGD","BK1191","BK1546","IE0034224299.USD","LU0878004406.USD","BK1554","BK1240","LU0228367735.SGD","LU0348788117.USD","LU0651946864.USD","BK1154","PAImain","LU0106959298.USD","LU0607220059.USD","06613","BK1184","02318","LU0048580855.USD","IE00BZ08YT58.USD","SG9999002562.SGD","BK1170","06127","LU0011963245.USD","LU0197773673.USD","LU1242518931.SGD","IE00BYV24P56.USD","LU0516422440.USD","LU0456827905.SGD","LU0762540952.USD","IE00B3M56506.USD","LU1481107354.HKD","LU1807302812.USD","LU1993786604.SGD","LU0348825331.USD","LU1105468828.SGD","LU0561508036.HKD","LU0293314216.USD","LU0882747503.HKD","LU1048588211.SGD","HK0000306701.USD","LU0244354667.USD","HK0000252152.HKD","BK1583","01812","LU0469268626.HKD","LU0320764755.SGD","LU0084288322.USD","LU0589944569.HKD","LU0918141705.HKD","LU0228659784.USD","BK1223","LU0531971595.HKD","LU0149534421.HKD","LU0196878994.USD","SG9999002463.SGD","LU2153591404.USD","03143","BK1105","LU0210527791.USD","LU0348827113.USD","LU1244550221.USD","LU0501845795.SGD","LU0516422366.SGD","LU0049112450.USD","IE00BGHQDM52.EUR","IE0032431581.USD","06745","LU0231483743.USD","01349","LU0828237510.HKD","LU0823426308.USD","IE00BF5LJ272.USD","BK1503","LU0611395673.USD","LU0588546209.SGD","LU1044874839.SGD","LU0229945570.USD","00553","LU1226287529.USD","LU1366334651.USD","LU2348773727.SGD","601318","LU0173614495.USD","BK1541","LU0819123356.HKD","BK1610","LU0540923850.HKD","LU1211504680.USD","LU0328353924.USD","LU0348784397.USD","LU0868486357.SGD","LU0862451837.USD","LU1051768304.USD","IE0008369823.USD","06655","IE00B031J352.USD","BK1526","SG9999004220.SGD","LU0543330483.HKD","LU1794554557.SGD","LU0831103253.SGD","LU0314109678.HKD","LU1224709979.USD","BK1522","IE00B543WZ88.USD","BK1533","LU0630378429.USD","BK1530","BK1594","02475","BK1116","HK0001040143.USD","LU0051755006.USD","159982","LU1244550494.USD","LU0463099449.HKD","LU0197773160.USD","HK0000352291.HKD","LU1688375341.USD","IE00B031HY20.USD","BK1147","03678","LU1224444064.USD","BK1125","00991","LU1282649067.USD","HK0000151867.HKD","LU0039217434.USD","82318","LU0890818403.SGD","BK1149","IE0031814852.USD","BK1505","LU1282651121.HKD","HK0000252160.HKD","LU0675040207.SGD","LU2476274720.SGD","SG9999006597.SGD","LU0163747925.USD","LU0823426480.USD","LU0865486749.SGD","LU0307460666.USD","LU2039709279.SGD","LU0327786744.USD","LU0762541174.USD","BK1562","SG9999000459.SGD","BK1122","LU1720050803.USD","LU1188198961.HKD","BK1576","BK1110","LU0348783233.USD","BK1141","LU2152927971.USD","LU0588545904.SGD","LU0417516902.SGD","LU0043850808.USD","LU1960683339.HKD","BK1560","LU0067412154.USD","LU0791590937.USD","LU0856984785.SGD","LU0441854154.USD","LU0348783662.USD","LU1048596156.SGD","00916","LU1046422090.SGD","LU1642822792.SGD","LU2294711473.HKD","LU1244550577.SGD","HK0000286598.CNH","02218","LU0784639295.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177922465","title":"HENGRUI PHARMA Shares Surge Over 4% in Late Trading as China's First Anti-HER2 Product for Colorectal Cancer Gains Market Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1177922465","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177922465?lang=en_us&edition=fundamental","pubTime":"2026-08-07 15:24","pubTimestamp":1786087459,"startTime":"0","endTime":"0","summary":"HENGRUI PHARMA (01276) shares climbed more than 4% in late trading, currently up 3.9% to HK$58.6, with a trading volume of HK$220 million. On August 6, the company announced that the third indication...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828557.USD","LU2580892862.HKD","LU1023057109.AUD","600276","LU2495084118.USD","IPOS","LU2097828805.USD","BK4588","LU1146622755.USD","LU1064130708.USD","LU1781817850.SGD","LU2097828714.EUR","LU1064131003.USD","BK0012","LU0359201612.USD","LU2289578879.USD","BK1191","LU2488822045.USD","BK0188","BK0028","BK0060","BK0183","LU1969619763.USD","LU2097828631.EUR","LU2543165471.USD","LU0359201885.HKD","LU2580892789.USD","LU2097828474.EUR","LU1655091616.SGD","LU1255011170.USD","LU1997245177.USD","BK4585","LU0359202008.SGD","LU1997244956.HKD","VXUS","KCAI","BK0239","LU1997245094.SGD","LU2148510915.USD","LU1328615791.USD","BK0196","LU0405327494.USD","LU0405327148.USD","01276","LU1820825898.SGD","LU2328871848.SGD","LU1580142542.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185344761","title":"Movement Alert｜HENGRUI PHARMA Rises 3.1% in Regular Trading, Two Innovative Drugs Approved for New Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=1185344761","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185344761?lang=en_us&edition=fundamental","pubTime":"2026-08-07 13:21","pubTimestamp":1786080078,"startTime":"0","endTime":"0","summary":"On August 7, HENGRUI PHARMA rose 3.1% in regular trading, trading at HKD 57.9/share, with turnover of HKD 131 million.The rally was primarily driven by the simultaneous approval of two innovative...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657634143","title":"Hengrui Pharma Unit Gets Marketing Nod for Colorectal Cancer Drug in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2657634143","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657634143?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:54","pubTimestamp":1786020887,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals  unit Suzhou Suncadia Biopharmaceuticals' third indication for trastuzumab rezetecan for injection was approved for marketing by China's National Medical Products Administration.The drug is now the first anti-HER2 product approved for the treatment of colorectal cancer in China.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1023057109.AUD","LU0359202008.SGD","01276","LU0359201885.HKD","LU0359201612.USD","LU2543165471.USD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165330909","title":"Hengrui Pharma Secures China’s First Anti-HER2 Approval for Colorectal Cancer with Trastuzumab Rezetecan","url":"https://stock-news.laohu8.com/highlight/detail?id=1165330909","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165330909?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:44","pubTimestamp":1786020250,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma, 01276) has received National Medical Products Administration (NMPA) clearance for a third indication of its in-house developed antibody-drug...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657631627","title":"Jiangsu Hengrui Pharmaceuticals - Nmpa Approved Additional (Fifth) Indication for Ivarmacitinib Sulfate Tablets (Shr0302 Tablets)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657631627","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657631627?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:40","pubTimestamp":1786020015,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nFWN4430WZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2580892862.HKD","LU1997245177.USD","LU2495084118.USD","LU1997244956.HKD","LU2543165471.USD","LU1820825898.SGD","LU0359201612.USD","LU1023057109.AUD","LU0405327494.USD","BK0028","LU1580142542.USD","LU2097828474.EUR","LU2328871848.SGD","LU2097828714.EUR","LU1328615791.USD","LU1255011170.USD","LU0359202008.SGD","LU0405327148.USD","LU1064131003.USD","LU2097828631.EUR","BK0188","LU2488822045.USD","LU1064130708.USD","LU1655091616.SGD","BK1191","BK0183","LU0359201885.HKD","LU2097828557.USD","LU2148510915.USD","LU1997245094.SGD","01276","BK0012","BK0196","LU2097828805.USD","BK0060","LU1781817850.SGD","BK0239","LU2580892789.USD","600276","LU1969619763.USD","LU1146622755.USD","LU2289578879.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657327631","title":"Jiangsu Hengrui Pharmaceuticals - Nmpa Approves Third Indication for Trastuzumab Rezetecan for Injection for Marketing in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2657327631","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657327631?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:34","pubTimestamp":1786019685,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nFWN44319M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2148510915.USD","LU1146622755.USD","01276","600276","LU1781817850.SGD","LU2328871848.SGD","LU2580892789.USD","LU1023057109.AUD","LU2289578879.USD","LU0359201885.HKD","LU2495084118.USD","LU1997245094.SGD","LU1064130708.USD","LU2097828631.EUR","LU1969619763.USD","LU1064131003.USD","LU2097828474.EUR","LU2097828714.EUR","BK0028","LU1997244956.HKD","BK0196","BK0239","LU1820825898.SGD","BK0012","BK0060","LU1997245177.USD","LU0405327494.USD","LU2097828805.USD","BK0188","LU1328615791.USD","LU0359202008.SGD","LU1580142542.USD","BK0183","LU1655091616.SGD","LU2488822045.USD","LU0405327148.USD","LU1255011170.USD","LU0359201612.USD","LU2543165471.USD","LU2580892862.HKD","BK1191","LU2097828557.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142719906","title":"JAK1 Inhibitor Aisuda Secures Fifth Indication Approval for Active Non-Radiographic Axial Spondyloarthritis","url":"https://stock-news.laohu8.com/highlight/detail?id=1142719906","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142719906?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:11","pubTimestamp":1786018284,"startTime":"0","endTime":"0","summary":"A pivotal Phase III study has met its primary endpoint, with the Aisuda (ivarmacitinib sulfate) group achieving a 39.7% ASAS40 response rate at 12 weeks, compared to 24.8% in the placebo group...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1023057109.AUD","BK1191","LU0359201885.HKD","LU0359202008.SGD","LU0359201612.USD","01276","BK4202","AS","LU2543165471.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167903648","title":"Jiangsu Hengrui Pharmaceuticals Secures Approval for Third Indication of Its Anti-HER2 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1167903648","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167903648?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:40","pubTimestamp":1786016414,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd. (600276.SH) has announced that its subsidiary, Suzhou Sundia Biopharmaceuticals Co., Ltd., received approval from the National Medical Products Administration...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1023057109.AUD","LU2580892862.HKD","LU1820825898.SGD","LU1146622755.USD","LU1328615791.USD","LU1064130708.USD","LU1969619763.USD","BK1191","LU2543165471.USD","BK0188","LU0405327148.USD","LU2148510915.USD","IPOS","LU0359202008.SGD","LU1997244956.HKD","LU1580142542.USD","BK0012","LU2580892789.USD","LU1781817850.SGD","LU2289578879.USD","LU0405327494.USD","LU2488822045.USD","LU1655091616.SGD","BK0183","LU1997245094.SGD","LU0359201885.HKD","LU2097828805.USD","LU2097828557.USD","LU2097828714.EUR","LU1997245177.USD","01276","600276","LU2328871848.SGD","LU2097828474.EUR","LU1064131003.USD","LU2097828631.EUR","BK0060","LU1255011170.USD","LU0359201612.USD","BK0239","LU2495084118.USD","BK0028","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657031682","title":"Citigroup’s Long Position in H-Shares of Jiangsu Hengrui Pharmaceuticals Increases to 5.06% on July 31 from 4.46% - HKEX Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2657031682","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657031682?lang=en_us&edition=fundamental","pubTime":"2026-08-06 18:30","pubTimestamp":1786012206,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nFWN4430J9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0405327148.USD","01276","LU0359201612.USD","LU1997245177.USD","LU1820825898.SGD","BK0183","LU0359202008.SGD","LU2097828474.EUR","LU1064130708.USD","LU2580892862.HKD","LU1997244956.HKD","LU2097828714.EUR","LU0359201885.HKD","LU2097828631.EUR","LU2495084118.USD","LU1781817850.SGD","LU2580892789.USD","LU1328615791.USD","LU2488822045.USD","BK0188","LU1064131003.USD","BK0012","LU2148510915.USD","600276","BK0028","LU2097828557.USD","LU1655091616.SGD","LU1023057109.AUD","BK0196","BK0239","LU1255011170.USD","BK0060","LU1997245094.SGD","LU2097828805.USD","LU1969619763.USD","LU2328871848.SGD","LU2543165471.USD","BK1191","LU1146622755.USD","LU1580142542.USD","LU2289578879.USD","LU0405327494.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130856515","title":"HENGRUI PHARMA's Zhang Lianshan: Global Strategy at a Turning Point, Innovative Drug Firms Must Ultimately Go Global Independently","url":"https://stock-news.laohu8.com/highlight/detail?id=1130856515","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130856515?lang=en_us&edition=fundamental","pubTime":"2026-08-06 10:00","pubTimestamp":1785981647,"startTime":"0","endTime":"0","summary":"The life sciences industry is undergoing a significant value reassessment, driven by AI's accelerated entry into clinical settings, a surge in global innovation deals, a shift in medical devices from...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0359201612.USD","BK0060","BK0188","LU0359201885.HKD","LU1023057109.AUD","LU2580892789.USD","IBBQ","LU2097828805.USD","LU2148510915.USD","LU0405327494.USD","LU1781817850.SGD","BK1574","LU2488822045.USD","BK0196","LU1580142542.USD","LU2495084118.USD","LU1146622755.USD","01276","LU2289578879.USD","LU0359202008.SGD","LU1820825898.SGD","BK0012","LU2097828557.USD","LU1997245094.SGD","LU2097828631.EUR","BK1161","LU1969619763.USD","BK0183","LU2328871848.SGD","LU1255011170.USD","MEDX","LNGR","LU2097828714.EUR","LU0405327148.USD","LU1997244956.HKD","BK1191","06978","159992","LU1064130708.USD","LU1997245177.USD","LU1328615791.USD","LU2580892862.HKD","LU1064131003.USD","LU2097828474.EUR","BK0028","BK0239","LU1655091616.SGD","LU2543165471.USD","600276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183354060","title":"Movement Alert｜HENGRUI PHARMA Falls 3.09% in Regular Trading, Trading at HK$56.35","url":"https://stock-news.laohu8.com/highlight/detail?id=1183354060","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183354060?lang=en_us&edition=fundamental","pubTime":"2026-08-06 10:00","pubTimestamp":1785981643,"startTime":"0","endTime":"0","summary":"On August 6, HENGRUI PHARMA fell 3.09% in regular trading, trading at HK$56.35/share, with turnover of HK$59.01 million.Within the Pharmaceuticals sector where HENGRUI PHARMA belongs, the overall...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138299745","title":"Cross-Market Valuation Disparities: Top A-H Share Premium Rankings as of August 5th","url":"https://stock-news.laohu8.com/highlight/detail?id=1138299745","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138299745?lang=en_us&edition=fundamental","pubTime":"2026-08-05 16:22","pubTimestamp":1785918139,"startTime":"0","endTime":"0","summary":"As of the close on August 5th, the top three positions in the A-H share premium ranking were held by NE ELECTRIC (00042), ZHEJIANG SHIBAO (01057), and SINOPEC SSC (01033), with premiums of 988.71%,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1550","01812","03968","01688","LU2399975544.HKD","IE00BMCWC346.EUR","BK1610","LU0039217434.USD","LU1770034418.SGD","LU0531971595.HKD","HK0001040143.USD","PAImain","LU0593848301.USD","LU0862451837.USD","BK1223","159982","LU0210526637.USD","LU2097828557.USD","LU0543330566.HKD","BK1231","LU2476274308.USD","SG9999002828.SGD","HK0000306685.HKD","BK1226","LU2543165471.USD","LU1634259557.SGD","LU1303224171.USD","LU0868486357.SGD","LU0516422952.EUR","SG9999001226.SGD","LU0117841782.USD","HK0001040168.HKD","LU0762542818.HKD","IE00B543WZ88.USD","LU0791591158.USD","00991","LU1044874839.SGD","LU0828237510.HKD","LU2153592121.USD","LU0359201885.HKD","LU0819121731.USD","LU0449515922.USD","LU0823040885.USD","LU0359202008.SGD","LU0862451753.SGD","LU0140636845.USD","LU0348735423.USD","LU0630378429.USD","BK1214","IE0008368742.USD","BK1546","LU0328353924.USD","LU0463099449.HKD","LU2348774022.SGD","LU0531970944.HKD","LU1969619763.USD","BK1558","03143","LU1242518931.SGD","LU0293314216.USD","LU0307460666.USD","BK1554","LU0588546209.SGD","LU0011963245.USD","LU0878005551.USD","LU0708995583.HKD","LU0675040207.SGD","LU0348766576.USD","LU0197773160.USD","IE00B0169L03.USD","IE00BVYPNP33.GBP","LU1785774172.SGD","BK1116","LU0072913022.USD","LU0594300419.USD","02208","LU0348767384.USD","SGXZ62798434.SGD","LU0049853897.USD","LU0502904849.HKD","LU2153591404.USD","LU0890818403.SGD","00895","LU0456846285.SGD","LU0455707207.USD","LU0762540952.USD","LU1282649067.USD","IE0031814852.USD","LU1961090484.USD","LU0469268626.HKD","BK1576","LU2293587155.HKD","01057","BK1140","02465","00042","LU0235996351.USD","LU0106252389.USD","LU1880383366.USD","LU2097828631.EUR","BK1513","LU0165289439.USD","LU0865486749.SGD","BK1105","02318","LU1993786604.SGD","03678","LU0540923850.HKD","LU0244354667.USD","LU0561508036.HKD","LU1794554557.SGD","SG9999000459.SGD","BK1521","LU1675838814.USD","LU0516423091.SGD","BK1205","IE0003895053.USD","LU0181495838.USD","LU0831103253.SGD","BK1163","BK1537","03750","LU2226246903.HKD","IE00BZ08YR35.GBP","LU2097828714.EUR","IE00B5MMRT66.SGD","IE00B031J352.USD","LU2097828474.EUR","LU0456827905.SGD","LU1152091754.HKD","HK0000252160.HKD","SG9999002562.SGD","LU1046422090.SGD","LU0320764599.SGD","HK0000252152.HKD","02768","LU0797268264.HKD","82318","LU0672654166.SGD","LU1282649141.HKD","LU1655091459.SGD","SG9999006597.SGD","LU0588545490.SGD","LU2348773727.SGD","BK1141","IE00BZ08YS42.EUR","BK1594","LU0828237940.HKD","LU0871576103.HKD","01276","BK1154","LU0979878070.USD","LU1051768304.USD","LU0605514214.HKD","BK1147","LU0327786744.USD","LU0431992006.USD","BK1506","BK1144","00638","01108","LU0348816934.USD","LU2039709279.SGD","IE00B031HY20.USD","BK1110","LU0417516902.SGD","LU0588545904.SGD","IE00B19Z5X02.USD","LU2294711473.HKD","LU0831093199.SGD","02359","LU0287142896.SGD","BK1514","LU0972618739.USD","HK0000352382.USD","LU0228367735.SGD","LU0029875118.USD","LU0488056044.USD","LU0918141887.USD","LU0449509016.USD","399300","LU1188198961.HKD","00857","BK1149","LU1282649810.SGD","LU1720050803.USD","LU1224444064.USD","BK1562","HK0000352291.HKD","LU0051755006.USD","LU0067412154.USD","LU2097828805.USD","EWH","LU2242644610.SGD","LU2045819591.USD","BK1526","03328","LU1282648689.USD","LU1820825898.SGD","LU0651946864.USD","LU0882747503.HKD","LU0634319403.HKD","LU1769817096.USD","LU1808992512.USD","LU1146622755.USD","LU1244550577.SGD","IE0034224299.USD","LU0878004406.USD","LU1481107354.HKD","BK1528","BK1583","LU1634259391.SGD","LU1244550494.USD","IE0032431581.USD","LU0594300179.USD","SG9999014674.SGD","LU1044875133.USD","LU0163747925.USD","LU0348805143.USD","06745","LU0650527681.SGD","LU0918141705.HKD","HPAD.SI","LU1251922891.USD","LU1497734951.SGD","LU0405327148.USD","IE00BQJZWZ67.USD","SG9999002463.SGD","LU1226287529.USD","LU0326950275.SGD","BK1507","LU2476274720.SGD","IE00BWDBJ730.SGD","LU0211977185.USD","LU1366334578.USD","03145","IE00B29SXG58.USD","LU0173614495.USD","LU1152091168.USD","LU0348783233.USD","BK1202","LU1051769294.HKD","LU0054450605.USD","LU1813983027.USD","LU1211504680.USD","IE00BF5LJ272.USD","LU0149534421.HKD","SG9999011746.SGD","LU1048596156.SGD","LU1044876610.USD","LU0196878994.USD","06655","BK1240","LU1807302812.USD","LU1688375341.USD","BK1607","01635","02338","LU0049112450.USD","LU1048588211.SGD","IE0008369823.USD","LU1105468828.SGD","LU0823426480.USD","LU0210527791.USD","LU0856984785.SGD","BK1135","LU1008478684.HKD","06031","00300","LU0117844026.USD","LU0417516571.SGD","LU1328277881.USD","BK1552","LU1719994722.HKD","LU0823426308.USD","LU0589944569.HKD","LU0588545730.USD","LU0640798160.USD","LU0164880469.USD","LU1515016050.SGD","LU0229945570.USD","LU0516423174.USD","LU0048580855.USD","LU0254981946.USD","LU0348788117.USD","LU0784639295.USD","IE00BYV24P56.USD","IE00BPRC5H50.USD","SG9999001093.SGD","BK1522","LU1960683339.HKD","00763","LU0149721374.USD","BK1560","01033","SG9999003461.SGD","BK1221","LU2328871848.SGD","601318","LU0315178854.USD","LU1981816686.USD","HK0000320264.USD","LU0228659784.USD","LU0231483743.USD","LU1366334651.USD","LU0821914370.USD","LU2125910500.SGD","LU1880383440.USD","HK0000500386.USD","IE00BZ08YT58.USD","BK1191","02691","LU0072462343.USD","LU0572944931.SGD","LU0516422366.SGD","LU0880133367.SGD","IE00BGHQDM52.EUR","LU0315179316.USD","LU0052750758.USD","LU0417516738.SGD","LU0164872284.USD","LU0516422440.USD","BK1529","LU0320764755.SGD","LU0106959298.USD","LU0348827113.USD","LU2778985437.USD","02218","LU0819123356.HKD","HK0000151867.HKD","LU0651947912.USD","LU0405327494.USD","03986","BK1551","LU0384037296.USD","BK1530","BK1125","LU0359201612.USD","01349","LU1282651121.HKD","LU1769817179.HKD","LU0348825331.USD","LU0607220059.USD","LU0648948544.HKD","BK1564","HK0000320223.HKD","SG9999004220.SGD","LU0214875030.USD","LU0791590937.USD","LU0164865239.USD","LU1497733557.USD","HK0000306701.USD","06127","LU0630378692.HKD","LU0197773673.USD","LU0128522157.USD","LU0762541174.USD","LU0501845795.SGD","LU1497733631.SGD","LU1244550221.USD","LU0441854154.USD","IE00B3M56506.USD","06613","LU0348784397.USD","BK1170","00916","00553","HK0000286598.CNH","LU0348783662.USD","LU0737861699.HKD","LU1115378108.SGD","LU2152927971.USD","LU1235295612.USD","LU0314109678.HKD","LU1023057109.AUD","LU0043850808.USD","LU0898667661.SGD","LU1224709979.USD","LU0348814723.USD","LU0084288322.USD","LU2424517915.HKD","LU1282651048.USD","PNGAY","LU1831875114.USD","SGXZ86797644.SGD","BK1184","SG9999001903.USD","LU1522347837.USD","BK1171","IE00BVYPNQ40.USD","LU0370786039.SGD","LU1242518857.USD","LU0543330483.HKD","LU0611395673.USD","BK1237","LU1642822792.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657959193","title":"Hengrui Pharmaceuticals Gets China Nod for Lung Cancer Combo Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2657959193","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657959193?lang=en_us&edition=fundamental","pubTime":"2026-08-05 10:47","pubTimestamp":1785898047,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals (SHA:600276, HKG:1276) obtained China's regulatory approval for Phase Two clinical trials combining SHR-A2009 with Adebrelimab or third-generation EGFR-TKI in non-small cell lung cancer patients, according to a Tuesday aftermarket filing with the Shanghai bourse.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","LU0359202008.SGD","LU2543165471.USD","LU0359201885.HKD","LU0359201612.USD","01276","LU1023057109.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185803437","title":"Hengrui Pharma Completes 13.75 Million Share Buyback as of July 31","url":"https://stock-news.laohu8.com/highlight/detail?id=1185803437","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185803437?lang=en_us&edition=fundamental","pubTime":"2026-08-04 18:12","pubTimestamp":1785838339,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd. (SSE: 600276) has disclosed its latest share repurchase progress, revealing that as of July 31, 2026, the company had cumulatively bought back 13.75 million...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0359201612.USD","LU1820825898.SGD","LU1064131003.USD","BK0188","01276","LU1023057109.AUD","LU0359201885.HKD","LU1969619763.USD","LU2148510915.USD","LU1655091616.SGD","LU1146622755.USD","LU2495084118.USD","LU2097828805.USD","LU2097828714.EUR","LU2097828557.USD","LU0405327494.USD","BK0239","LU0405327148.USD","BK1191","LU1255011170.USD","LU1997244956.HKD","LU2488822045.USD","BK0028","LU2580892862.HKD","LU1328615791.USD","LU2289578879.USD","LU2580892789.USD","LU2097828631.EUR","LU0359202008.SGD","LU1781817850.SGD","LU2097828474.EUR","LU1064130708.USD","600276","LU2543165471.USD","LU1997245094.SGD","LU1997245177.USD","BK0012","LU2328871848.SGD","BK0060","BK0183","BK0196","LU1580142542.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}